Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NK1 homeobox 1 (NKX1-1) is a member of the NKX family of homeodomain-containing transcription factors and functions as a critical regulator of organ development through transcriptional regulation[1][6][3]. It may also play a role in the maintenance of energy homeostasis by interacting with factors involved in these processes[3][6]. There is no evidence this gene is a therapeutic target in the sense of being modulated by approved drugs, nor is it classified as a receptor, enzyme, or similar protein targeted by small molecules or biologics. Its aliases include alternative names relating to its gene and protein family. Mice studies suggest a role in obesity and metabolic regulation, but clinical significance in human diseases is not established[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NK1 homeobox 1 (NKX1-1).